← Back to headlines
Debate Intensifies Over Drug Costs and Availability in Austria
A debate is ongoing in Austria regarding the rising costs and limited availability of medications, with calls from officials for the pharmaceutical industry to ensure fair and sustainable pricing as social security costs for medicines have significantly increased.
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
orfGerman24d ago
Debatte über Kosten und Verfügbarkeit von Medikamenten
Read full article →die-presseGerman24d ago
Schumann fordert von Pharmaindustrie „faire und nachhaltige Preise“
Die Kosten der Sozialversicherung für die Heilmittelversorgung lagen vergangenes Jahr bei 4,9 Milliarden. Gegenüber 2013 ist das ein Anstieg um 88,2 Prozent.
Read full article →Coverage Timeline
First report: die-presse · 16 Jul, 10:24|Full coverage: 2 · 8m|Window: 8m
Left-leaningCenterRight-leaning
